Illumina Ventures

Illumina Ventures is a Foster City, California-based U.S. life-sciences venture capital firm originally established as the independent successor to Illumina Inc. (NASDAQ: ILMN; the world's leading genomic-sequencing instrumentation company)'s corporate venture arm, spun out to operate as an independent VC while maintaining a strategic relationship with Illumina Inc. The firm invests in early-stage life-sciences tools, clinical diagnostics, therapeutics, precision-medicine, genomics-applied companies, and adjacent life-sciences themes where Illumina-platform-enabled or genomics-data-driven innovations are central. Illumina Ventures has raised multiple institutional funds (Fund I in 2017 at USD 230 million with Illumina Inc. as anchor LP) with aggregate AUM in the USD hundreds of millions, typically writing initial check sizes in the USD 3 to 15 million range at Series A and Series B stages. Notable portfolio companies include Helix, SeqWell, Ultima Genomics, Somalogic, GRAIL (formerly Illumina subsidiary), AiCure, and numerous other genomics, diagnostics, and precision-medicine ventures.